BRTX vs MS · rev $401.0K vs P/E 20, $344.27B cap
BioRestorative Therapies Inc (BRTX) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
MS does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the BRTX and MS stock pages for the full models.
Not investment advice.